Authors:
Gulini, U
Angeli, P
Marucci, G
Buccioni, M
Giardina, D
Antolini, L
Franchini, S
Sorbi, C
Brasili, L
Citation: U. Gulini et al., Synthesis, absolute configuration and antimuscarinic activity of the enantiomers of [1-(2,2-diphenyl-[1,3]dioxolan-4-yl)-ethyl]dimethyl-amine, BIOORG MED, 11(2), 2001, pp. 247-250
Authors:
Pigini, M
Quaglia, W
Gentili, F
Marucci, G
Cantalamessa, F
Franchini, S
Sorbi, C
Brasili, L
Citation: M. Pigini et al., Structure-activity relationship at alpha-adrenergic receptors within a series of imidazoline analogues of cirazoline, BIO MED CH, 8(5), 2000, pp. 883-888
Authors:
Greney, H
Ronde, P
Magnier, C
Maranca, F
Rascente, C
Quaglia, W
Giannella, M
Pigini, M
Brasili, L
Lugnier, C
Bousquet, P
Dontenwill, M
Citation: H. Greney et al., Coupling of I-1 imidazoline receptors to the cAMP pathway: Studies with a highly selective ligand, benazoline, MOLEC PHARM, 57(6), 2000, pp. 1142-1151
Authors:
Angeli, P
Brasili, L
Franchini, S
Giardina, D
Gulini, U
Marucci, G
Citation: P. Angeli et al., Effect of aromatic substitution on antimuscarinic activity of 2-phenyl-2-cyclohexyl-4-[(dimethylamino)methyl]-1,3-dioxolanes, MED CHEM RE, 9(2), 1999, pp. 89-97
Authors:
Quaglia, W
Bousquet, P
Pigini, M
Carotti, A
Carrieri, A
Dontenwill, M
Gentili, F
Giannella, M
Maranca, F
Piergentili, A
Brasili, L
Citation: W. Quaglia et al., 2-(2-phenylcyclopropyl) imidazolines: Reversed enantioselective interaction at I-1 and I-2 imidazoline receptors, J MED CHEM, 42(15), 1999, pp. 2737-2740
Authors:
Malmusi, L
Franchini, S
Mucci, A
Angeli, P
Gulini, U
Marucci, G
Brasili, L
Citation: L. Malmusi et al., Synthesis and antimuscarinic activity of some N-(4-dimethylaminomethyl-2-phenyl-[1,3]dioxolan-2-ylmethyl)lactam methiodides, MED CHEM RE, 8(9), 1998, pp. 499-509
Authors:
Pigini, M
Bousquet, P
Brasili, L
Carrieri, A
Cavagna, R
Dontenwill, M
Gentili, F
Giannella, M
Leonetti, F
Piergentili, A
Quaglia, W
Carotti, A
Citation: M. Pigini et al., Ligand binding to I-2 imidazoline receptor: The role of lipophilicity in quantitative structure-activity relationship models, BIO MED CH, 6(12), 1998, pp. 2245-2260